The role of data and safety monitoring boards in implementation trials: When are they justified?
- PMID: 32695494
- PMCID: PMC7348012
- DOI: 10.1017/cts.2020.19
The role of data and safety monitoring boards in implementation trials: When are they justified?
Abstract
The National Institutes of Health requires data and safety monitoring boards (DSMBs) for all phase III clinical trials. The National Heart, Lung and Blood Institute requires DSMBs for all clinical trials involving more than one site and those involving cooperative agreements and contracts. These policies have resulted in the establishment of DSMBs for many implementation trials, with little consideration regarding the appropriateness of DSMBs and/or key adaptations needed by DSMBs to monitor data quality and participant safety. In this perspective, we review the unique features of implementation trials and reflect on key questions regarding the justification for DSMBs and their potential role and monitoring targets within implementation trials.
Keywords: Clinical trials data monitoring committee; National Institutes of Health; clinical trials as topic; data and safety monitoring; delivery science; implementation science; translational medical research.
© The Association for Clinical and Translational Science 2020.
Similar articles
-
Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.Clin Trials. 2011 Dec;8(6):727-35. doi: 10.1177/1740774511425181. Epub 2011 Oct 24. Clin Trials. 2011. PMID: 22024105
-
Data safety monitoring boards: legal and ethical considerations for research accountability.Account Res. 2010 Jan;17(1):30-50. doi: 10.1080/08989620903520313. Account Res. 2010. PMID: 20094929
-
Data safety and monitoring boards for African clinical trials.Trans R Soc Trop Med Hyg. 2008 Dec;102(12):1189-94. doi: 10.1016/j.trstmh.2008.06.009. Epub 2008 Jul 21. Trans R Soc Trop Med Hyg. 2008. PMID: 18644610
-
Independent Oversight of Clinical Trials through Data and Safety Monitoring Boards.NEJM Evid. 2022 Jan;1(1):EVIDctw2100005. doi: 10.1056/EVIDctw2100005. Epub 2022 Jan 10. NEJM Evid. 2022. PMID: 38319172 Review.
-
An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.J Clin Epidemiol. 2016 Jan;69:152-60. doi: 10.1016/j.jclinepi.2015.05.023. Epub 2015 Jun 4. J Clin Epidemiol. 2016. PMID: 26361993 Review.
Cited by
-
A pragmatic, stepped-wedge, hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis for patients with traumatic brain injury.Implement Sci. 2024 Aug 5;19(1):57. doi: 10.1186/s13012-024-01386-4. Implement Sci. 2024. PMID: 39103955 Free PMC article.
-
Do no harm: the impact of implementing cancer prevention strategies on other preventive health measures.Implement Sci Commun. 2024 May 22;5(1):58. doi: 10.1186/s43058-024-00597-6. Implement Sci Commun. 2024. PMID: 38778390 Free PMC article.
-
Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case Studies.Mayo Clin Proc. 2023 Nov;98(11):1712-1726. doi: 10.1016/j.mayocp.2023.02.019. Mayo Clin Proc. 2023. PMID: 37923529 Free PMC article. Review.
-
Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.Trials. 2023 Apr 21;24(1):288. doi: 10.1186/s13063-023-07313-0. Trials. 2023. PMID: 37085877 Free PMC article. Clinical Trial.
-
Maternal Perceptions of Safeguards for Research Involving Children.J Child Fam Stud. 2022 May;31(5):1220-1231. doi: 10.1007/s10826-021-02037-8. Epub 2021 Aug 7. J Child Fam Stud. 2022. PMID: 35875400 Free PMC article.
References
-
- Gordon VM, Sugarman J, Kass N. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials. IRB 1998; 20(1): 1–5. - PubMed
-
- U.S. Department of Health and Human Services. Electronic Code of Federal Regulations: eCFR, Part 46-Protections of Human Subjects, 46.102 (e) [Internet], 2018 [cited Jan 31, 2020]. (https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=83cd09e1c0f5c6937cd9d7...)
-
- Slutsky AS, Lavery JV. Data safety and monitoring boards. The New England Journal of Medicine 2004; 350(11): 1143–1147. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources